Administration of therapeutic-dose versus prophylactic-dose anticoagulation with heparins is associated with lower 28-day mortality.

The FDA has granted a speedy review of Eli Lilly and Boehringer Ingelheim’s Jardiance for a potential new use, to reduce the risk of renal failure and cardiovascular death in people with chronic ...

Available globally, the MG Cyberster features scissor doors and 20-inch dual-tone alloy wheels on the exterior. The cabin comes with a triple-screen setup, which includes a 7-inch infotainment system.

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has been approved for chronic kidney disease in the EU - the first major market to clear the new use for the drug. Adding CKD to the ...

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

If you're interested in exploring more stocks under $20 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Stocks under $20 offer investors and ...

Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic ...

Tirzepatide treatment was associated with reduced body weight and diabetes risk across 3 years among individuals with obesity and prediabetes.

According to Columbia University’s Center for Metabolic and Weight Loss Surgery, deciding to take drugs like Ozempic requires ...

Note :Financial Information is based on consolidated numbers.